<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR205">
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Smith</surname>
    <given-names>G</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>Y</given-names>
   </name>
   <name>
    <surname>Flyer</surname>
    <given-names>D</given-names>
   </name>
   <name>
    <surname>Massare</surname>
    <given-names>MJ</given-names>
   </name>
   <name>
    <surname>Zhou</surname>
    <given-names>B</given-names>
   </name>
   <name>
    <surname>Patel</surname>
    <given-names>N</given-names>
   </name>
   <name>
    <surname>Ellingsworth</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Lewis</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Cummings</surname>
    <given-names>JF</given-names>
   </name>
   <name>
    <surname>Glenn</surname>
    <given-names>G</given-names>
   </name>
  </person-group>
  <article-title>Novel hemagglutinin nanoparticle influenza vaccine with Matrix-Mâ„¢ adjuvant induces hemagglutination inhibition, neutralizing, and protective responses in ferrets against homologous and drifted A(H3N2) subtypes</article-title>
  <source>Vaccine</source>
  <year>2017</year>
  <volume>35</volume>
  <fpage>5366</fpage>
  <lpage>5372</lpage>
  <pub-id pub-id-type="doi">10.1016/j.vaccine.2017.08.021</pub-id>
  <?supplied-pmid 28844407?>
  <pub-id pub-id-type="pmid">28844407</pub-id>
 </element-citation>
</ref>
